NEA Management Company’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,141,308
Closed -$8.45M 70
2021
Q3
$8.45M Hold
4,141,308
0.1% 52
2021
Q2
$12.3M Hold
4,141,308
0.16% 51
2021
Q1
$11.4M Hold
4,141,308
0.26% 49
2020
Q4
$10.1M Hold
4,141,308
0.27% 43
2020
Q3
$8.7M Hold
4,141,308
0.37% 40
2020
Q2
$15.7M Hold
4,141,308
0.63% 28
2020
Q1
$7.83M Hold
4,141,308
0.41% 33
2019
Q4
$8.66M Hold
4,141,308
0.41% 33
2019
Q3
$9.9M Hold
4,141,308
0.82% 23
2019
Q2
$13M Hold
4,141,308
0.91% 26
2019
Q1
$20.6M Hold
4,141,308
1.07% 22
2018
Q4
$18.6M Hold
4,141,308
0.74% 21
2018
Q3
$20.1M Hold
4,141,308
0.87% 27
2018
Q2
$24.8M Hold
4,141,308
1.16% 20
2018
Q1
$36.7M Hold
4,141,308
1.63% 16
2017
Q4
$30M Hold
4,141,308
1.24% 19
2017
Q3
$28.6M Hold
4,141,308
1% 20
2017
Q2
$29.6M Hold
4,141,308
1.08% 18
2017
Q1
$19.7M Hold
4,141,308
0.68% 19
2016
Q4
$9.94M Buy
4,141,308
+2,000,000
+93% +$8.15M 0.4% 21
2016
Q3
$11.2M Hold
2,141,308
0.5% 22
2016
Q2
$8.52M Hold
2,141,308
0.44% 23
2016
Q1
$9.76M Hold
2,141,308
0.65% 21
2015
Q4
$16.3M Buy
+2,141,308
New +$15.4M 1.04% 18

NEA Management Company's SBBP Position: Q4 2021 in Review

NEA Management Company sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 4,141,308 shares — an estimated $8.45M sold.

NEA Management Company first reported a position in SBBP in Q4 2015 and held it in 24 quarters. The position peaked at $36.7M in Q1 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • NEA Management Company reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • NEA Management Company sold 4,141,308 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $8.45M.
  • NEA Management Company first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 24 quarters.
  • NEA Management Company's Strongbridge Biopharma plc. position peaked at $36.7M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.